Antibody-drug conjugates (ADCs) are one of the fastest-growing classes of therapies in precision oncology. In this guide to adc drugs by target, we provide a comprehensive and updated overview of approved antibody-drug conjugates, together with their classification based on tumor targets. 🚀 As of March 2026, approximately 21 ADC drugs have been approved worldwide, targeting … Continue reading ADC Drugs by Target (2026 Update): Full List of Approved ADCs, Pipeline and Trends